title: Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis.
authors.forename: M
authors.initials: M
authors.lastname: Fukagawa
authors.forename: R
authors.initials: R
authors.lastname: Okazaki
authors.forename: K
authors.initials: K
authors.lastname: Takano
authors.forename: S
authors.initials: S
authors.lastname: Kaname
authors.forename: E
authors.initials: E
authors.lastname: Ogata
authors.forename: M
authors.initials: M
authors.lastname: Kitaoka
authors.forename: S
authors.initials: S
authors.lastname: Harada
authors.forename: N
authors.initials: N
authors.lastname: Sekine
authors.forename: T
authors.initials: T
authors.lastname: Matsumoto
authors.forename: K
authors.initials: K
authors.lastname: Kurokawa
mesh_terms: D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D002117:Calcitriol / Q000008:administration & dosage* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy / Q000209:etiology; D006965:Hyperplasia; D010280:Parathyroid Glands / Q000473:pathology*; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium